Platelet Aggregation Inhibitors
"Platelet Aggregation Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
| Descriptor ID |
D010975
|
| MeSH Number(s) |
D27.505.954.502.780
|
| Concept/Terms |
Platelet Aggregation Inhibitors- Platelet Aggregation Inhibitors
- Aggregation Inhibitors, Platelet
- Inhibitors, Platelet Aggregation
- Blood Platelet Antiaggregants
- Antiaggregants, Blood Platelet
- Platelet Antiaggregants
- Antiaggregants, Platelet
- Blood Platelet Aggregation Inhibitors
Antiplatelet Agents- Antiplatelet Agents
- Agents, Antiplatelet
- Antiplatelet Drugs
- Drugs, Antiplatelet
Platelet Antagonists- Platelet Antagonists
- Antagonists, Platelet
- Blood Platelet Antagonists
- Antagonists, Blood Platelet
|
Below are MeSH descriptors whose meaning is more general than "Platelet Aggregation Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Platelet Aggregation Inhibitors".
This graph shows the total number of publications written about "Platelet Aggregation Inhibitors" by people in this website by year, and whether "Platelet Aggregation Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 2 | 3 |
| 1999 | 0 | 5 | 5 |
| 2000 | 1 | 2 | 3 |
| 2001 | 4 | 2 | 6 |
| 2002 | 2 | 4 | 6 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 3 | 1 | 4 |
| 2006 | 4 | 0 | 4 |
| 2007 | 2 | 1 | 3 |
| 2008 | 4 | 3 | 7 |
| 2009 | 3 | 5 | 8 |
| 2010 | 3 | 2 | 5 |
| 2011 | 2 | 0 | 2 |
| 2012 | 4 | 3 | 7 |
| 2013 | 4 | 1 | 5 |
| 2014 | 3 | 1 | 4 |
| 2015 | 6 | 3 | 9 |
| 2016 | 9 | 6 | 15 |
| 2017 | 7 | 7 | 14 |
| 2018 | 14 | 1 | 15 |
| 2019 | 9 | 8 | 17 |
| 2020 | 5 | 1 | 6 |
| 2021 | 6 | 6 | 12 |
| 2022 | 5 | 7 | 12 |
| 2023 | 0 | 4 | 4 |
| 2024 | 5 | 2 | 7 |
| 2025 | 5 | 2 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Platelet Aggregation Inhibitors" by people in Profiles.
-
One-year clinical outcomes in patients with acute coronary syndrome treated with clopidogrel versus prasugrel versus ticagrelor: Results of the Polish Registry of Acute Coronary Syndromes (PL-ACS). Kardiol Pol. 2025; 83(10):1142-1151.
-
Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin? Cardiol J. 2025; 32(3):321-327.
-
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial. J Am Coll Cardiol. 2025 Apr 01; 85(12):1317-1331.
-
Impact of desmopressin on hematoma expansion in patients presenting to the emergency department on antiplatelet therapy. Am J Emerg Med. 2025 Jul; 93:126-131.
-
Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint. Cardiol J. 2025; 32(2):189-194.
-
Impact of Perioperative Anticoagulation and Antiplatelet Therapy on Hearing Preservation Outcomes. Otol Neurotol. 2025 Feb 01; 46(2):128-132.
-
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint. Cardiol J. 2025; 32(1):83-89.
-
Meta-Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clin Cardiol. 2024 Oct; 47(10):e70026.
-
A Multicenter Evaluation of Clopidogrel Resistance and Its Role in Predicting Stent Thrombosis in Transcarotid Artery Revascularization. Ann Vasc Surg. 2025 Jan; 110(Pt A):226-232.
-
Abbreviated ticagrelor based dual antiplatelet therapy in acute coronary syndrome: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2025 Jun; 75:64-70.